While evidence linking SNP34091 status to breast cancer risk has been at variance [21–24], we recently found the MDM4 SNP34091AC genotype to be associated with a reduced risk of breast cancer among individuals carrying the MDM2 SNP309GG genotype [17], a genotype, in general, associated with elevated cancer risk [33, 34]. This evidence concerns the gene MDM2 and cancer.